| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations
|
Aidoo, Michael
|
|
2007
|
25 |
Supplement 1 |
p. 6474-6481
8 p.
|
artikel
|
| 2 |
A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan
|
Nagai, Takao
|
|
2007
|
25 |
Supplement 1 |
p. 2742-2747
6 p.
|
artikel
|
| 3 |
Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminum-containing adjuvants
|
Sokolovska, Anna
|
|
2007
|
25 |
Supplement 1 |
p. 4575-4585
11 p.
|
artikel
|
| 4 |
Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP–IPV–PRP∼T–HBs) combination vaccine
|
Stojanov, S.
|
|
2007
|
25 |
Supplement 1 |
p. 7549-7558
10 p.
|
artikel
|
| 5 |
A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination
|
Cassataro, Juliana
|
|
2007
|
25 |
Supplement 1 |
p. 5958-5967
10 p.
|
artikel
|
| 6 |
Advances in Immunology and Vaccine Discovery
|
Gay, Cyril G.
|
|
2007
|
25 |
Supplement 1 |
p. 7007-7011
5 p.
|
artikel
|
| 7 |
Advances in methods for the production, purification, and characterization of HIV-1 Gag–Env pseudovirion vaccines
|
Hammonds, Jason
|
|
2007
|
25 |
Supplement 1 |
p. 8036-8048
13 p.
|
artikel
|
| 8 |
A dynamic model for assessing universal Hepatitis A vaccination in Canada
|
Bauch, C.T.
|
|
2007
|
25 |
Supplement 1 |
p. 1719-1726
8 p.
|
artikel
|
| 9 |
Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005
|
Ceyhan, Mehmet
|
|
2007
|
25 |
Supplement 1 |
p. 7233-7237
5 p.
|
artikel
|
| 10 |
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions
|
Rourou, Samia
|
|
2007
|
25 |
Supplement 1 |
p. 3879-3889
11 p.
|
artikel
|
| 11 |
Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains
|
Tano, Yoshio
|
|
2007
|
25 |
Supplement 1 |
p. 7041-7046
6 p.
|
artikel
|
| 12 |
Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: Implications for vaccine development
|
Yuen, Don
|
|
2007
|
25 |
Supplement 1 |
p. 490-499
10 p.
|
artikel
|
| 13 |
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11
|
Slupetzky, Katharina
|
|
2007
|
25 |
Supplement 1 |
p. 2001-2010
10 p.
|
artikel
|
| 14 |
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults
|
Kester, Kent E.
|
|
2007
|
25 |
Supplement 1 |
p. 5359-5366
8 p.
|
artikel
|
| 15 |
A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination
|
Cassataro, Juliana
|
|
2007
|
25 |
Supplement 1 |
p. 4437-4446
10 p.
|
artikel
|
| 16 |
A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells
|
Marzio, G.
|
|
2007
|
25 |
Supplement 1 |
p. 2228-2237
10 p.
|
artikel
|
| 17 |
A sensitive cell-based assay for the detection of residual infectious West Nile virus
|
Koldijk, M.H.
|
|
2007
|
25 |
Supplement 1 |
p. 6872-6881
10 p.
|
artikel
|
| 18 |
A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months
|
Tsang, Cemaine
|
|
2007
|
25 |
Supplement 1 |
p. 5485-5494
10 p.
|
artikel
|
| 19 |
Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis
|
García-Yoldi, David
|
|
2007
|
25 |
Supplement 1 |
p. 2858-2862
5 p.
|
artikel
|
| 20 |
Attenuating characteristics of DEN-2 PDK53 in flavivirus-naïve peripheral blood mononuclear cells
|
Rabablert, Jundee
|
|
2007
|
25 |
Supplement 1 |
p. 3896-3905
10 p.
|
artikel
|
| 21 |
Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge
|
Bråve, Andreas
|
|
2007
|
25 |
Supplement 1 |
p. 6882-6890
9 p.
|
artikel
|
| 22 |
Caprine herpesvirus 1 vaccine with the LTK63 mutant as a mucosal adjuvant induces strong protection against genital infection in goats
|
Tempesta, M.
|
|
2007
|
25 |
Supplement 1 |
p. 7927-7930
4 p.
|
artikel
|
| 23 |
Cattle immune response to botulinum type D toxoid: Results of a vaccination study
|
Steinman, A.
|
|
2007
|
25 |
Supplement 1 |
p. 7636-7640
5 p.
|
artikel
|
| 24 |
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
|
Kistner, Otfried
|
|
2007
|
25 |
Supplement 1 |
p. 6028-6036
9 p.
|
artikel
|
| 25 |
Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: A 16-year study
|
Torzillo, Paul J.
|
|
2007
|
25 |
Supplement 1 |
p. 2375-2378
4 p.
|
artikel
|
| 26 |
Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid
|
Silveira, I.A.F.B.
|
|
2007
|
25 |
Supplement 1 |
p. 7261-7270
10 p.
|
artikel
|
| 27 |
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
|
Gruener, Norbert H.
|
|
2007
|
25 |
Supplement 1 |
p. 4960-4966
7 p.
|
artikel
|
| 28 |
Characterization of the antibody response elicited by HIV-1 Env glycomutants in rabbits
|
Reynard, F.
|
|
2007
|
25 |
Supplement 1 |
p. 535-546
12 p.
|
artikel
|
| 29 |
Chemokine and cytokine gene expression profiles in chickens inoculated with Mycoplasma gallisepticum strains R low or GT5
|
Mohammed, Javed
|
|
2007
|
25 |
Supplement 1 |
p. 8611-8621
11 p.
|
artikel
|
| 30 |
Chitosan solution enhances the immunoadjuvant properties of GM-CSF
|
Zaharoff, David A.
|
|
2007
|
25 |
Supplement 1 |
p. 8673-8686
14 p.
|
artikel
|
| 31 |
Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine
|
Karpenko, Larisa I.
|
|
2007
|
25 |
Supplement 1 |
p. 4312-4323
12 p.
|
artikel
|
| 32 |
Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques
|
Chong, Siew-Yen
|
|
2007
|
25 |
Supplement 1 |
p. 4967-4982
16 p.
|
artikel
|
| 33 |
Comparative efficacy of an indigenous ‘inactivated vaccine’ using highly pathogenic field strain of Mycobacterium avium subspecies paratuberculosis ‘Bison type’ with a commercial vaccine for the control of Capri-paratuberculosis in India
|
Singh, S.V.
|
|
2007
|
25 |
Supplement 1 |
p. 7102-7110
9 p.
|
artikel
|
| 34 |
Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines
|
Wan, Yanmin
|
|
2007
|
25 |
Supplement 1 |
p. 4949-4959
11 p.
|
artikel
|
| 35 |
Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: Otitis media and acute pneumonia
|
Cripps, Allan W.
|
|
2007
|
25 |
Supplement 1 |
p. 2471-2477
7 p.
|
artikel
|
| 36 |
Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine
|
Álvarez, M.
|
|
2007
|
25 |
Supplement 1 |
p. 6613-6617
5 p.
|
artikel
|
| 37 |
Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation
|
Liang, Rong
|
|
2007
|
25 |
Supplement 1 |
p. 5994-6006
13 p.
|
artikel
|
| 38 |
Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic
|
Malhotra, Uma
|
|
2007
|
25 |
Supplement 1 |
p. 381-390
10 p.
|
artikel
|
| 39 |
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: A strategy for enhancing immunogenicity of malaria vaccine candidates
|
Qian, Feng
|
|
2007
|
25 |
Supplement 1 |
p. 3923-3933
11 p.
|
artikel
|
| 40 |
Construction and evaluation of a multistage combination vaccine against malaria
|
Zhang, Qingfeng
|
|
2007
|
25 |
Supplement 1 |
p. 2112-2119
8 p.
|
artikel
|
| 41 |
Construction and immunogenicity of recombinant adenovirus expressing the major outer membrane protein (MOMP) of Chlamydophila psittaci in chicks
|
Zhou, Jizhang
|
|
2007
|
25 |
Supplement 1 |
p. 6367-6372
6 p.
|
artikel
|
| 42 |
Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli
|
Roland, Kenneth L.
|
|
2007
|
25 |
Supplement 1 |
p. 8574-8584
11 p.
|
artikel
|
| 43 |
Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: Preclinical evidence of immunogenicity and protection
|
Xu, De Qi
|
|
2007
|
25 |
Supplement 1 |
p. 6167-6175
9 p.
|
artikel
|
| 44 |
Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3–14 years from the provider and societal perspectives
|
Navas, E.
|
|
2007
|
25 |
Supplement 1 |
p. 3233-3239
7 p.
|
artikel
|
| 45 |
Countries
|
|
|
2007
|
25 |
Supplement 1 |
p. C27-C219
nvt p.
|
artikel
|
| 46 |
Cytokine gene expression patterns associated with immunization against Marek's disease in chickens
|
Abdul-Careem, Mohamed Faizal
|
|
2007
|
25 |
Supplement 1 |
p. 424-432
9 p.
|
artikel
|
| 47 |
Delivery of DNA vaccines by agarose hydrogel implants facilitates genetic immunization in cattle
|
Toussaint, J.F.
|
|
2007
|
25 |
Supplement 1 |
p. 1167-1174
8 p.
|
artikel
|
| 48 |
Dermal testing of vaccines for children at high risk of allergies
|
Sugai, Kazuko
|
|
2007
|
25 |
Supplement 1 |
p. 3454-3463
10 p.
|
artikel
|
| 49 |
Design and characterization of an HIV-1 Tat mutant: Inactivation of viral and cellular functions but not antigenicity
|
Mayol, Katia
|
|
2007
|
25 |
Supplement 1 |
p. 6047-6060
14 p.
|
artikel
|
| 50 |
Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people
|
Boot, Hein J.
|
|
2007
|
25 |
Supplement 1 |
p. 4706-4714
9 p.
|
artikel
|
| 51 |
Developing an HPV vaccine to prevent cervical cancer and genital warts
|
Bryan, Janine T.
|
|
2007
|
25 |
Supplement 1 |
p. 3001-3006
6 p.
|
artikel
|
| 52 |
Development and registration of recombinant veterinary vaccines
|
Poulet, Hervé
|
|
2007
|
25 |
Supplement 1 |
p. 5606-5612
7 p.
|
artikel
|
| 53 |
Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection
|
Thorpe, Callum
|
|
2007
|
25 |
Supplement 1 |
p. 2252-2260
9 p.
|
artikel
|
| 54 |
DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity
|
Buonaguro, L.
|
|
2007
|
25 |
Supplement 1 |
p. 5968-5977
10 p.
|
artikel
|
| 55 |
Dose–response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost
|
Liu, Jinyan
|
|
2007
|
25 |
Supplement 1 |
p. 2951-2958
8 p.
|
artikel
|
| 56 |
Dose–response to type V group B streptococcal polysaccharide–tetanus toxoid conjugate vaccine in healthy adults
|
Baker, Carol J.
|
|
2007
|
25 |
Supplement 1 |
p. 55-63
9 p.
|
artikel
|
| 57 |
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers
|
Goepfert, Paul A.
|
|
2007
|
25 |
Supplement 1 |
p. 510-518
9 p.
|
artikel
|
| 58 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 59 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 60 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 61 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 62 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 63 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 64 |
Editorial Board
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 65 |
Editorial Board/Aims and Scope
|
|
|
2007
|
25 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 66 |
Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens
|
Uddowla, Sabena
|
|
2007
|
25 |
Supplement 1 |
p. 7984-7993
10 p.
|
artikel
|
| 67 |
Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine
|
Zhang, Xiaofei
|
|
2007
|
25 |
Supplement 1 |
p. 3254-3262
9 p.
|
artikel
|
| 68 |
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag
|
Santos, Kathlyn
|
|
2007
|
25 |
Supplement 1 |
p. 1634-1646
13 p.
|
artikel
|
| 69 |
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis
|
Watts, Douglas M.
|
|
2007
|
25 |
Supplement 1 |
p. 2913-2918
6 p.
|
artikel
|
| 70 |
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs
|
Shu, Yuuei
|
|
2007
|
25 |
Supplement 1 |
p. 1398-1408
11 p.
|
artikel
|
| 71 |
Epidemiology of invasive Haemophilus influenzae type b disease in Singapore children, 1994–2003
|
Thoon, Koh Cheng
|
|
2007
|
25 |
Supplement 1 |
p. 6482-6489
8 p.
|
artikel
|
| 72 |
Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave® Bioreactor microcarrier culture in 1–10L scale
|
Hundt, B.
|
|
2007
|
25 |
Supplement 1 |
p. 3987-3995
9 p.
|
artikel
|
| 73 |
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005–2006 season of dual A and B vaccine mismatch in Canada
|
Skowronski, D.M.
|
|
2007
|
25 |
Supplement 1 |
p. 2842-2851
10 p.
|
artikel
|
| 74 |
Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice
|
Song, Shuxia
|
|
2007
|
25 |
Supplement 1 |
p. 4853-4860
8 p.
|
artikel
|
| 75 |
Evaluation of combinatorial vaccines against anthrax and plague in a murine model
|
DuBois, Amanda B.
|
|
2007
|
25 |
Supplement 1 |
p. 4747-4754
8 p.
|
artikel
|
| 76 |
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model
|
Rollman, Erik
|
|
2007
|
25 |
Supplement 1 |
p. 2145-2154
10 p.
|
artikel
|
| 77 |
Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy
|
Rossi, Renato E.
|
|
2007
|
25 |
Supplement 1 |
p. 957-964
8 p.
|
artikel
|
| 78 |
Expression library immunization confers partial protection against Chlamydia muridarum genital infection
|
McNeilly, Celia L.
|
|
2007
|
25 |
Supplement 1 |
p. 2643-2655
13 p.
|
artikel
|
| 79 |
Factors influencing the antibody response of dogs vaccinated against rabies
|
Kennedy, Lorna J.
|
|
2007
|
25 |
Supplement 1 |
p. 8500-8507
8 p.
|
artikel
|
| 80 |
FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice
|
Luo, Yunping
|
|
2007
|
25 |
Supplement 1 |
p. 1409-1415
7 p.
|
artikel
|
| 81 |
Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs
|
Orsel, K.
|
|
2007
|
25 |
Supplement 1 |
p. 6381-6391
11 p.
|
artikel
|
| 82 |
Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin
|
Lagergård, Teresa
|
|
2007
|
25 |
Supplement 1 |
p. 3606-3614
9 p.
|
artikel
|
| 83 |
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits
|
Guillon, Christophe
|
|
2007
|
25 |
Supplement 1 |
p. 7491-7501
11 p.
|
artikel
|
| 84 |
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
|
Gómez, Carmen Elena
|
|
2007
|
25 |
Supplement 1 |
p. 1969-1992
24 p.
|
artikel
|
| 85 |
Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children
|
Heeg, Christiane
|
|
2007
|
25 |
Supplement 1 |
p. 1030-1035
6 p.
|
artikel
|
| 86 |
Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus
|
de Souza, Ana Paula D.
|
|
2007
|
25 |
Supplement 1 |
p. 109-116
8 p.
|
artikel
|
| 87 |
Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice
|
Yang, Zhigang
|
|
2007
|
25 |
Supplement 1 |
p. 161-169
9 p.
|
artikel
|
| 88 |
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial
|
Hermsen, Cornelus C.
|
|
2007
|
25 |
Supplement 1 |
p. 2930-2940
11 p.
|
artikel
|
| 89 |
GTU®-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model
|
Malm, Maria
|
|
2007
|
25 |
Supplement 1 |
p. 3293-3301
9 p.
|
artikel
|
| 90 |
Guillain–Barre syndrome after vaccination in United States
|
Souayah, Nizar
|
|
2007
|
25 |
Supplement 1 |
p. 5253-5255
3 p.
|
artikel
|
| 91 |
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B
|
Gómez, Carmen Elena
|
|
2007
|
25 |
Supplement 1 |
p. 2863-2885
23 p.
|
artikel
|
| 92 |
Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years
|
Hammitt, Laura L.
|
|
2007
|
25 |
Supplement 1 |
p. 6958-6964
7 p.
|
artikel
|
| 93 |
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
|
Stamataki, Zania
|
|
2007
|
25 |
Supplement 1 |
p. 7773-7784
12 p.
|
artikel
|
| 94 |
Herd immunity and pneumococcal conjugate vaccine: A quantitative model
|
Haber, Michael
|
|
2007
|
25 |
Supplement 1 |
p. 5390-5398
9 p.
|
artikel
|
| 95 |
High immunogenicity of delayed third dose of hepatitis B vaccine in travellers
|
Jackson, Yves
|
|
2007
|
25 |
Supplement 1 |
p. 3482-3484
3 p.
|
artikel
|
| 96 |
HIV-189.6 Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice
|
Parker, Scott D.
|
|
2007
|
25 |
Supplement 1 |
p. 6764-6773
10 p.
|
artikel
|
| 97 |
Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan
|
Chen, Kow-Tong
|
|
2007
|
25 |
Supplement 1 |
p. 4266-4272
7 p.
|
artikel
|
| 98 |
HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime
|
Duke, Cindy M.P.
|
|
2007
|
25 |
Supplement 1 |
p. 7410-7421
12 p.
|
artikel
|
| 99 |
Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection
|
Linder, Adam
|
|
2007
|
25 |
Supplement 1 |
p. 341-345
5 p.
|
artikel
|
| 100 |
Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine
|
Barreto, L.
|
|
2007
|
25 |
Supplement 1 |
p. 8172-8179
8 p.
|
artikel
|
| 101 |
Identification of pentadecapeptide mimicking muramyl peptide
|
Laman, Alexander Georgievich
|
|
2007
|
25 |
Supplement 1 |
p. 2900-2906
7 p.
|
artikel
|
| 102 |
Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus
|
Li, Yun-Gang
|
|
2007
|
25 |
Supplement 1 |
p. 902-911
10 p.
|
artikel
|
| 103 |
Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis
|
Moreno, J.
|
|
2007
|
25 |
Supplement 1 |
p. 5290-5300
11 p.
|
artikel
|
| 104 |
Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling
|
Cai, Qiliang
|
|
2007
|
25 |
Supplement 1 |
p. 5155-5165
11 p.
|
artikel
|
| 105 |
Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium
|
Costa, Wagner A.
|
|
2007
|
25 |
Supplement 1 |
p. 8140-8145
6 p.
|
artikel
|
| 106 |
Immunogenicity and safety of a virosomal hepatitis A vaccine in HIV-positive patients
|
Loutan, L.
|
|
2007
|
25 |
Supplement 1 |
p. 6310-6312
3 p.
|
artikel
|
| 107 |
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998–2006)
|
Oosterhuis-Kafeja, Froukje
|
|
2007
|
25 |
Supplement 1 |
p. 2194-2212
19 p.
|
artikel
|
| 108 |
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
|
van den Dobbelsteen, Germie P.J.M.
|
|
2007
|
25 |
Supplement 1 |
p. 2491-2496
6 p.
|
artikel
|
| 109 |
Immunogenicity of a subunit vaccine against Bacillus anthracis
|
Chichester, Jessica A.
|
|
2007
|
25 |
Supplement 1 |
p. 3111-3114
4 p.
|
artikel
|
| 110 |
Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice
|
Deshmukh, Tejaswini M.
|
|
2007
|
25 |
Supplement 1 |
p. 4350-4360
11 p.
|
artikel
|
| 111 |
Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice
|
Devi, Yengkhom Sangeeta
|
|
2007
|
25 |
Supplement 1 |
p. 5166-5174
9 p.
|
artikel
|
| 112 |
Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state
|
Kim, Mikyung
|
|
2007
|
25 |
Supplement 1 |
p. 5102-5114
13 p.
|
artikel
|
| 113 |
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
|
Jackson, Lisa A.
|
|
2007
|
25 |
Supplement 1 |
p. 4029-4037
9 p.
|
artikel
|
| 114 |
Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins
|
Quan, Fu-Shi
|
|
2007
|
25 |
Supplement 1 |
p. 3841-3850
10 p.
|
artikel
|
| 115 |
Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: A randomised controlled trial
|
Heron, Leon
|
|
2007
|
25 |
Supplement 1 |
p. 2817-2822
6 p.
|
artikel
|
| 116 |
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants
|
Esposito, Susanna
|
|
2007
|
25 |
Supplement 1 |
p. 4889-4894
6 p.
|
artikel
|
| 117 |
Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1
|
Fischer, Geferson
|
|
2007
|
25 |
Supplement 1 |
p. 1250-1256
7 p.
|
artikel
|
| 118 |
Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate
|
Cano, Jean Paul
|
|
2007
|
25 |
Supplement 1 |
p. 4382-4391
10 p.
|
artikel
|
| 119 |
Impact of variation in acute virulence of BVDV1 strains on design of better vaccine efficacy challenge models
|
Ridpath, Julia F.
|
|
2007
|
25 |
Supplement 1 |
p. 8058-8066
9 p.
|
artikel
|
| 120 |
Implementation of good clinical practice guidelines in vaccine trials in developing countries
|
Acosta, Camilo J.
|
|
2007
|
25 |
Supplement 1 |
p. 2852-2857
6 p.
|
artikel
|
| 121 |
Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity
|
Carra, John H.
|
|
2007
|
25 |
Supplement 1 |
p. 4149-4158
10 p.
|
artikel
|
| 122 |
Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870
|
Koeberling, Oliver
|
|
2007
|
25 |
Supplement 1 |
p. 1912-1920
9 p.
|
artikel
|
| 123 |
IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study
|
Brignone, Chrystelle
|
|
2007
|
25 |
Supplement 1 |
p. 4641-4650
10 p.
|
artikel
|
| 124 |
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans
|
Eller, Michael A.
|
|
2007
|
25 |
Supplement 1 |
p. 7737-7742
6 p.
|
artikel
|
| 125 |
Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine
|
Calarota, Sandra A.
|
|
2007
|
25 |
Supplement 1 |
p. 3070-3074
5 p.
|
artikel
|
| 126 |
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
|
Olsson, Sven-Eric
|
|
2007
|
25 |
Supplement 1 |
p. 4931-4939
9 p.
|
artikel
|
| 127 |
Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases
|
Shi, Frank F.
|
|
2007
|
25 |
Supplement 1 |
p. 3338-3346
9 p.
|
artikel
|
| 128 |
Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut
|
Lin, S.W.
|
|
2007
|
25 |
Supplement 1 |
p. 2187-2193
7 p.
|
artikel
|
| 129 |
Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection
|
Cong, Yu
|
|
2007
|
25 |
Supplement 1 |
p. 3773-3780
8 p.
|
artikel
|
| 130 |
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection
|
Manuri, Pallavi R.
|
|
2007
|
25 |
Supplement 1 |
p. 3302-3310
9 p.
|
artikel
|
| 131 |
Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge
|
Munro, Patrick
|
|
2007
|
25 |
Supplement 1 |
p. 8702-8706
5 p.
|
artikel
|
| 132 |
Intravaginal administration of an inactivated vaccine prevents lesions induced by caprine herpesvirus-1 in goats
|
Camero, Michele
|
|
2007
|
25 |
Supplement 1 |
p. 1658-1661
4 p.
|
artikel
|
| 133 |
Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
|
Puthanakit, Thanyawee
|
|
2007
|
25 |
Supplement 1 |
p. 8257-8261
5 p.
|
artikel
|
| 134 |
Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis
|
Hwang, Shen-An
|
|
2007
|
25 |
Supplement 1 |
p. 6730-6743
14 p.
|
artikel
|
| 135 |
LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains
|
Zhu, C.
|
|
2007
|
25 |
Supplement 1 |
p. 1884-1892
9 p.
|
artikel
|
| 136 |
Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys
|
Jiang, Shisong
|
|
2007
|
25 |
Supplement 1 |
p. 7470-7479
10 p.
|
artikel
|
| 137 |
Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine
|
Asanuma, Hideki
|
|
2007
|
25 |
Supplement 1 |
p. 6975-6980
6 p.
|
artikel
|
| 138 |
Long-term colonisation–inhibition studies to protect broilers against colonisation with Salmonella Enteritidis, using Salmonella Pathogenicity Island 1 and 2 mutants
|
Bohez, Lotte
|
|
2007
|
25 |
Supplement 1 |
p. 4235-4243
9 p.
|
artikel
|
| 139 |
Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma
|
Zuccotti, Gianvincenzo
|
|
2007
|
25 |
Supplement 1 |
p. 6692-6698
7 p.
|
artikel
|
| 140 |
Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents
|
Gabbuti, Andrea
|
|
2007
|
25 |
Supplement 1 |
p. 3129-3132
4 p.
|
artikel
|
| 141 |
Major CD4 epitopes involved in anti-CD4 T-cell autoimmunity in HIV-1 patients
|
Abulafia-Lapid, Rivka
|
|
2007
|
25 |
Supplement 1 |
p. 3192-3199
8 p.
|
artikel
|
| 142 |
Manipulation of the infectious bronchitis coronavirus genome for vaccine development and analysis of the accessory proteins
|
Cavanagh, Dave
|
|
2007
|
25 |
Supplement 1 |
p. 5558-5562
5 p.
|
artikel
|
| 143 |
Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle
|
Abdul-Wahid, Aws
|
|
2007
|
25 |
Supplement 1 |
p. 8372-8383
12 p.
|
artikel
|
| 144 |
Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice
|
Ellis, John A.
|
|
2007
|
25 |
Supplement 1 |
p. 1085-1095
11 p.
|
artikel
|
| 145 |
Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses
|
Huang, Xianggang
|
|
2007
|
25 |
Supplement 1 |
p. 2620-2629
10 p.
|
artikel
|
| 146 |
Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses
|
Huang, Xianggang
|
|
2007
|
25 |
Supplement 1 |
p. 8874-8884
11 p.
|
artikel
|
| 147 |
Mycobacterium bovis BCG as a delivery system for the RAP-1 antigen from Babesia bovis
|
Santangelo, M.P.
|
|
2007
|
25 |
Supplement 1 |
p. 1104-1113
10 p.
|
artikel
|
| 148 |
New assays to measure equine influenza virus-specific Type 1 immunity in horses
|
Paillot, R.
|
|
2007
|
25 |
Supplement 1 |
p. 7385-7398
14 p.
|
artikel
|
| 149 |
Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag
|
Qiu, Jian-Tai
|
|
2007
|
25 |
Supplement 1 |
p. 253-263
11 p.
|
artikel
|
| 150 |
Novel marker vaccines against classical swine fever
|
Beer, Martin
|
|
2007
|
25 |
Supplement 1 |
p. 5665-5670
6 p.
|
artikel
|
| 151 |
Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines
|
Michel, Marie
|
|
2007
|
25 |
Supplement 1 |
p. 1901-1911
11 p.
|
artikel
|
| 152 |
Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules
|
Mercier, George T.
|
|
2007
|
25 |
Supplement 1 |
p. 8687-8701
15 p.
|
artikel
|
| 153 |
Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Effect of reducing or eliminating BCG load on cell-mediated immunity
|
Cross, M.L.
|
|
2007
|
25 |
Supplement 1 |
p. 1297-1303
7 p.
|
artikel
|
| 154 |
Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention
|
Esposito, Susanna
|
|
2007
|
25 |
Supplement 1 |
p. 6437-6446
10 p.
|
artikel
|
| 155 |
Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population
|
Rendi-Wagner, Pamela
|
|
2007
|
25 |
Supplement 1 |
p. 927-931
5 p.
|
artikel
|
| 156 |
Pertussis vaccine and infantile spasms
|
Lapatsanis, Petros
|
|
2007
|
25 |
Supplement 1 |
p. 404-405
2 p.
|
artikel
|
| 157 |
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults
|
Halperin, Scott A.
|
|
2007
|
25 |
Supplement 1 |
p. 450-457
8 p.
|
artikel
|
| 158 |
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
|
Catanzaro, Andrew T.
|
|
2007
|
25 |
Supplement 1 |
p. 4085-4092
8 p.
|
artikel
|
| 159 |
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research
|
Polhemus, Mark E.
|
|
2007
|
25 |
Supplement 1 |
p. 4203-4212
10 p.
|
artikel
|
| 160 |
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
|
Stoute, José A.
|
|
2007
|
25 |
Supplement 1 |
p. 176-184
9 p.
|
artikel
|
| 161 |
Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults
|
Scott, Daniel A.
|
|
2007
|
25 |
Supplement 1 |
p. 6164-6166
3 p.
|
artikel
|
| 162 |
Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes
|
Hui, George
|
|
2007
|
25 |
Supplement 1 |
p. 948-956
9 p.
|
artikel
|
| 163 |
Populations of pharyngeal meningococci in Niger
|
Nicolas, Pierre
|
|
2007
|
25 |
Supplement 1 |
p. A53-A57
nvt p.
|
artikel
|
| 164 |
Potential use an Actinobacillus pleuropneumoniae double mutant strain ΔapxIICΔapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals
|
Liu, Jinlin
|
|
2007
|
25 |
Supplement 1 |
p. 7696-7705
10 p.
|
artikel
|
| 165 |
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine
|
Lieberman, Michael M.
|
|
2007
|
25 |
Supplement 1 |
p. 414-423
10 p.
|
artikel
|
| 166 |
Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection
|
Pancré, Véronique
|
|
2007
|
25 |
Supplement 1 |
p. 5927-5937
11 p.
|
artikel
|
| 167 |
Prevenar™ vaccination: Review of the global data, 2006
|
Center, Kimberly J.
|
|
2007
|
25 |
Supplement 1 |
p. 3085-3089
5 p.
|
artikel
|
| 168 |
Prime-boost immunization with DNA, recombinant fowlpox virus and VLPSHIV elicit both neutralizing antibodies and IFNγ-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells
|
Radaelli, Antonia
|
|
2007
|
25 |
Supplement 1 |
p. 2128-2138
11 p.
|
artikel
|
| 169 |
Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease
|
Hsieh, Ming Kun
|
|
2007
|
25 |
Supplement 1 |
p. 5417-5427
11 p.
|
artikel
|
| 170 |
Private demand for cholera vaccines in Beira, Mozambique
|
Lucas, Marcelino E.S.
|
|
2007
|
25 |
Supplement 1 |
p. 2599-2609
11 p.
|
artikel
|
| 171 |
Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine
|
Greco, Raffaella
|
|
2007
|
25 |
Supplement 1 |
p. 8228-8240
13 p.
|
artikel
|
| 172 |
Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus
|
Quinlivan, Michelle
|
|
2007
|
25 |
Supplement 1 |
p. 7056-7064
9 p.
|
artikel
|
| 173 |
Prophylactic DNA immunization against multiple papillomavirus types
|
Gašparić, Maja
|
|
2007
|
25 |
Supplement 1 |
p. 4540-4553
14 p.
|
artikel
|
| 174 |
Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain
|
Martelli, Paolo
|
|
2007
|
25 |
Supplement 1 |
p. 3400-3408
9 p.
|
artikel
|
| 175 |
Protective efficacy of neutralizing antibodies against Ebola virus infection
|
Takada, Ayato
|
|
2007
|
25 |
Supplement 1 |
p. 993-999
7 p.
|
artikel
|
| 176 |
Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays
|
Skovsted, Ian Chr.
|
|
2007
|
25 |
Supplement 1 |
p. 6490-6500
11 p.
|
artikel
|
| 177 |
Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine
|
Smets, F.
|
|
2007
|
25 |
Supplement 1 |
p. 5278-5282
5 p.
|
artikel
|
| 178 |
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program
|
|
|
2007
|
25 |
Supplement 1 |
p. 3118-3123
6 p.
|
artikel
|
| 179 |
Rates of contraindications and use of alternative vaccines in routine immunisation of children: A population based study in the Czech Republic
|
Danova, Jana
|
|
2007
|
25 |
Supplement 1 |
p. 3890-3895
6 p.
|
artikel
|
| 180 |
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
|
Du, Lanying
|
|
2007
|
25 |
Supplement 1 |
p. 2832-2838
7 p.
|
artikel
|
| 181 |
Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B
|
Zhan, Xiaoyan
|
|
2007
|
25 |
Supplement 1 |
p. 8782-8793
12 p.
|
artikel
|
| 182 |
Role of respiratory syncytial virus in acute otitis media: Implications for vaccine development
|
Patel, Janak A.
|
|
2007
|
25 |
Supplement 1 |
p. 1683-1689
7 p.
|
artikel
|
| 183 |
Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults
|
Macaladad, N.
|
|
2007
|
25 |
Supplement 1 |
p. 2139-2144
6 p.
|
artikel
|
| 184 |
Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa
|
Sirima, Sodiomon B.
|
|
2007
|
25 |
Supplement 1 |
p. 2723-2732
10 p.
|
artikel
|
| 185 |
Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy
|
Dorrell, Lucy
|
|
2007
|
25 |
Supplement 1 |
p. 3277-3283
7 p.
|
artikel
|
| 186 |
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
|
Kshirsagar, Nilima
|
|
2007
|
25 |
Supplement 1 |
p. A101-A107
nvt p.
|
artikel
|
| 187 |
Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine
|
Partridge, Susan
|
|
2007
|
25 |
Supplement 1 |
p. 1806-1813
8 p.
|
artikel
|
| 188 |
Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia
|
Aseffa, Abraham
|
|
2007
|
25 |
Supplement 1 |
p. A79-A82
nvt p.
|
artikel
|
| 189 |
Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease
|
Nøkleby, H.
|
|
2007
|
25 |
Supplement 1 |
p. 3080-3084
5 p.
|
artikel
|
| 190 |
SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
|
Kitabatake, Masahiro
|
|
2007
|
25 |
Supplement 1 |
p. 630-637
8 p.
|
artikel
|
| 191 |
Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan
|
Liu, Ching-Yun
|
|
2007
|
25 |
Supplement 1 |
p. 7706-7710
5 p.
|
artikel
|
| 192 |
Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago
|
Wang, Li-Yu
|
|
2007
|
25 |
Supplement 1 |
p. 7160-7167
8 p.
|
artikel
|
| 193 |
Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus
|
Barabé, Nicole D.
|
|
2007
|
25 |
Supplement 1 |
p. 6271-6276
6 p.
|
artikel
|
| 194 |
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity
|
Peters, Barry S.
|
|
2007
|
25 |
Supplement 1 |
p. 2120-2127
8 p.
|
artikel
|
| 195 |
Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit–insulin B chain fusion protein vaccine produced in silkworm
|
Gong, Zhaohui
|
|
2007
|
25 |
Supplement 1 |
p. 1444-1451
8 p.
|
artikel
|
| 196 |
Surface simulation synthesis: A new strategy to spy α-helix structure
|
Dong, Xiao-Nan
|
|
2007
|
25 |
Supplement 1 |
p. 6569-6571
3 p.
|
artikel
|
| 197 |
Survey of poliovirus antibodies during the final stage of polio eradication in Egypt
|
El-Sayed, Nasr
|
|
2007
|
25 |
Supplement 1 |
p. 5062-5070
9 p.
|
artikel
|
| 198 |
Sustained measles elimination in Australia and priorities for long term maintenance
|
Gidding, Heather F.
|
|
2007
|
25 |
Supplement 1 |
p. 3574-3580
7 p.
|
artikel
|
| 199 |
Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice
|
Sharon, Melamed
|
|
2007
|
25 |
Supplement 1 |
p. 7743-7753
11 p.
|
artikel
|
| 200 |
Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties
|
Campbell, Grant R.
|
|
2007
|
25 |
Supplement 1 |
p. 8441-8447
7 p.
|
artikel
|
| 201 |
The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys
|
Rojas Caraballo, Jose
|
|
2007
|
25 |
Supplement 1 |
p. 3713-3721
9 p.
|
artikel
|
| 202 |
The clinical grade maturation cocktail monophosphoryl lipid A plus IFNγ generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization
|
ten Brinke, Anja
|
|
2007
|
25 |
Supplement 1 |
p. 7145-7152
8 p.
|
artikel
|
| 203 |
The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection
|
Kojima, Yoshitsugu
|
|
2007
|
25 |
Supplement 1 |
p. 438-445
8 p.
|
artikel
|
| 204 |
The effect of vaccination on foot and mouth disease virus transmission among dairy cows
|
Orsel, K.
|
|
2007
|
25 |
Supplement 1 |
p. 327-335
9 p.
|
artikel
|
| 205 |
The epidemiology and burden of rotavirus in China: A review of the literature from 1983 to 2005
|
Orenstein, Evan W.
|
|
2007
|
25 |
Supplement 1 |
p. 406-413
8 p.
|
artikel
|
| 206 |
The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents
|
Ortega-Barrìa, Eduardo
|
|
2007
|
25 |
Supplement 1 |
p. 8432-8440
9 p.
|
artikel
|
| 207 |
The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia
|
Gidding, Heather F.
|
|
2007
|
25 |
Supplement 1 |
p. 8637-8641
5 p.
|
artikel
|
| 208 |
The Meningitis Vaccine Project
|
LaForce, F. Marc
|
|
2007
|
25 |
Supplement 1 |
p. A97-A100
nvt p.
|
artikel
|
| 209 |
The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity
|
Park, Mi-Young
|
|
2007
|
25 |
Supplement 1 |
p. 7322-7330
9 p.
|
artikel
|
| 210 |
The preventable burden of pneumococcal disease in the developing world
|
Scott, J.A.G.
|
|
2007
|
25 |
Supplement 1 |
p. 2398-2405
8 p.
|
artikel
|
| 211 |
Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours
|
Chandy, Annie George
|
|
2007
|
25 |
Supplement 1 |
p. 6037-6046
10 p.
|
artikel
|
| 212 |
The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine
|
Hui, George
|
|
2007
|
25 |
Supplement 1 |
p. 8549-8556
8 p.
|
artikel
|
| 213 |
The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease
|
Hausdorff, William P.
|
|
2007
|
25 |
Supplement 1 |
p. 2406-2412
7 p.
|
artikel
|
| 214 |
Two vaccine toxicity-related genes Agp and Hpx could prove useful for pertussis vaccine safety control
|
Hamaguchi, Isao
|
|
2007
|
25 |
Supplement 1 |
p. 3355-3364
10 p.
|
artikel
|
| 215 |
Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses
|
Bublin, Merima
|
|
2007
|
25 |
Supplement 1 |
p. 8395-8404
10 p.
|
artikel
|
| 216 |
Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virus-induced Behcet's disease symptoms in mice
|
Lee, Seung Ihm
|
|
2007
|
25 |
Supplement 1 |
p. 7047-7055
9 p.
|
artikel
|
| 217 |
Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis
|
De Wals, Philippe
|
|
2007
|
25 |
Supplement 1 |
p. 5433-5440
8 p.
|
artikel
|
| 218 |
Vaccination associated thrombocytopenic purpura in children
|
Rajantie, J.
|
|
2007
|
25 |
Supplement 1 |
p. 1838-1840
3 p.
|
artikel
|
| 219 |
Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus
|
Odongo, David
|
|
2007
|
25 |
Supplement 1 |
p. 1287-1296
10 p.
|
artikel
|
| 220 |
Vaccination of chickens against Campylobacter
|
de Zoete, Marcel R.
|
|
2007
|
25 |
Supplement 1 |
p. 5548-5557
10 p.
|
artikel
|
| 221 |
Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín
|
Palmer, M.V.
|
|
2007
|
25 |
Supplement 1 |
p. 6589-6597
9 p.
|
artikel
|
| 222 |
Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3
|
Saini, Manisha
|
|
2007
|
25 |
Supplement 1 |
p. 8660-8663
4 p.
|
artikel
|
| 223 |
Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi
|
Timoney, John F.
|
|
2007
|
25 |
Supplement 1 |
p. 5583-5590
8 p.
|
artikel
|
| 224 |
Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients
|
Skull, Susan A.
|
|
2007
|
25 |
Supplement 1 |
p. 4775-4783
9 p.
|
artikel
|
| 225 |
Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses
|
Fine, Donald L.
|
|
2007
|
25 |
Supplement 1 |
p. 1868-1876
9 p.
|
artikel
|
| 226 |
Viral antigen production in cell cultures on microcarriers
|
Conceição, M.M.
|
|
2007
|
25 |
Supplement 1 |
p. 7785-7795
11 p.
|
artikel
|
| 227 |
What needs to be done for polio eradication in India?
|
Paul, Yash
|
|
2007
|
25 |
Supplement 1 |
p. 6431-6436
6 p.
|
artikel
|
| 228 |
WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1–2 June 2006
|
Ferguson, Morag
|
|
2007
|
25 |
Supplement 1 |
p. 5233-5243
11 p.
|
artikel
|
| 229 |
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins
|
Haller, Aurelia A.
|
|
2007
|
25 |
Supplement 1 |
p. 1452-1463
12 p.
|
artikel
|
| 230 |
Widening inequalities in MMR vaccine uptake rates among ethnic groups in an urban area of the UK during a period of vaccine controversy (1994–2000)
|
Hawker, Jeremy I.
|
|
2007
|
25 |
Supplement 1 |
p. 7516-7519
4 p.
|
artikel
|
Tijdschrift beschrijving